Stay informed with the latest updates for the inheritable blood disorders community.

NBDF & Community
MASAC Letter to the Community Regarding the Coronavirus Disease 2019
MASAC Letter to the Community Regarding the Coronavirus Disease 2019
NBDF & Community
Community Statement from Genentech on Hemlibra supply amid 2019-nCoV
Community Statement from Genentech on Hemlibra supply amid 2019-nCoV
NBDF & Community
Joint Statement on Recall of VONVENDI Lots
Joint Statement on Recall of VONVENDI Lots
NBDF & Community
Takeda announced a pharmacy-level recall of two lots of VONVENDI
Takeda announced a pharmacy-level recall of two lots of VONVENDI
NBDF & Community
Letter to the NHF Community
Letter to Our Community
NBDF & Community
How FDA is Putting the Patient Voice at the Forefront of Gene Therapy Clinical Trials for Hemophilia
How FDA is Putting the Patient Voice at the…
NBDF & Community
NHF Awarded 4-star Rating from Charity Navigator
NHF Awarded 4-star Rating from Charity Navigator
NBDF & Community
NHF, WFH, EHC Monitor Coronavirus Impact on Bleeding Disorders Community
NHF, WFH, EHC Monitor Coronavirus Impact on Bleeding Disorders Community
NBDF & Community
NHF and the Green Park Collaborative Launch Project to Measure Mental Health Outlook
NHF and the Green Park Collaborative Launch Project to Measure…
NBDF & Community
NHF/HFA Seek Feedback on Product Safety and Communication
NHF and HFA Hold Safety Summit
NBDF & Community
National Hemophilia Foundation Announces Next CEO
National Hemophilia Foundation Announces Next CEO
NBDF & Community
Patient Groups Urge Supreme Court to Swiftly Take Up Health Care Case
Patient Groups Urge Supreme Court to Swiftly Take Up Health Care Case
NBDF & Community
NHF and HFA Announce Safety Summit
NHF and HFA Announce Safety Summit
NBDF & Community
NHF Announces 2019 Kevin Child Scholarship Winner
NHF Announces 2019 Kevin Child Scholarship Winner
NBDF & Community
Genentech Response to NHF and HFA Questions Regarding Hemlibra
Genentech Response to NHF and HFA Questions Regarding Hemlibra